Cite
MLA Citation
Mark A. Socinski et al.. “Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer.” Therapeutic advances in medical oncology, vol. 13, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100137756498.0x000153